Skip to main content
. 2020 Mar 9;177(12):2696–2711. doi: 10.1111/bph.14996

Table 1.

Integrin pharmacology and targeted integrin subunit(s)

mAb Isotype Target
Efalizumab (Raptiva®) hIgG1 αL
R7.1 mIgG1 αL
TS1/22 mIgG1 αL
Natalizumab (Tysabri®) hIgG4 α4
Vedolizumab (Entyvio®) hIgG1 α4β7
Compound Class Target
LFA878 Statin derivative αL
BIRT377 Hydantoin derivative αL
XVA143 Peptidomimetic αLβ2
Lifitegrast (Xiidra®) Peptidomimetic αLβ2
Firategrast Peptidomimetic α4β1/α4β7
RO0505376 Peptidomimetic α4β1/α4β7

Abbreviations: h, human; m, mouse.